WAT
WATERS CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$434.27
−0.61%Margins
Gross margin
50.8%
EBITDA margin
20.5%
EBIT margin
8.0%
Net margin
3.6%
FCF margin
8.6%
1.1%
Return on equity
0.7%
Return on assets
1.8%
Return on invested capital
0.19x
Asset turnover
$549.9M
Cash from operations
$5.49
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jul 1, 2026